Carcinogenesis, Vol. 23, No. 12, 2111-2117,
December 2002
© 2002 Oxford University Press
CARCINOGENESIS |
Association of p16INK4a and pRb inactivation with immortalization of human cells
1 Department of Pharmacology, The Nippon Dental University, School of Dentistry at Tokyo, Tokyo 102-8159, Japan,
2 Department of Cellular and Molecular Biology, Hiroshima University, Graduated School of Biomedical Sciences, Hiroshima 734-8551, Japan and
3 National Institute of Environmental Health Sciences, PO Box 12233, Research Triangle Park, NC 27709, and National Cancer Institute, Bethesda, MD 20892, USA
| Abstract |
|---|
|
|
|---|
To examine the association of cell cycle regulatory gene inactivation with human cell immortalization, we determined the expression status of INK4a, Rb, and WAF1/ CIP1, in eleven in vitro immortalized human cell lines, including fibroblasts and keratinocytes. Two human papillomavirus type 16 E6 expressing cell lines with telomerase activity, including a fibroblast cell line and a keratinocyte cell line, expressed no detectable p16INK4a. These cell lines had a hyperphosphorylated pRb and reduced expression of p21WAF1/CIP1. All of seven fibroblast cell lines immortalized either spontaneously or by 60Co, X-rays, 4-nitroquinoline 1-oxide or aflatoxin B1, maintaining their telomeres by the ALT (alternative lengthening of telomeres) pathway, displayed loss of expression of p16INK4a and hyperphosphorylation of pRb. Levels of p21WAF1/CIP1 expression varied among the cell lines. Two fibroblast cell lines that became immortalized following infection with a retrovirus vector encoding human telomerase catalytic subunit (hTERT) cDNA were also accompanied by inactivation of p16INK4a and pRb pathways. Acquisition of telomerase activity alone was not sufficient for immortalization of these cell lines. Taken together, all the cell lines including fibroblasts and keratinocytes, with either telomerase activity or the ALT pathway for telomere maintenance showed loss of expression of p16INK4a and hyperphosphorylation of pRb. These demonstrate the association of inactivation of both p16INK4a and pRb with immortalization of human cells including fibroblasts and epithelial cells and telomerase-positive cells and ALT-positive cells.
Abbreviations: ALT, alternative lengthening of telomeres; CDK, cyclin-dependent kinase; ERK 1, extracellular-signal related kinase 1; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HPV, human papillomavirus; hTERT, human telomerase catalytic subunit; MSP, methylation-specific PCR; ppRb, hyperphosphorylated pRb; pRb, retinoblastoma gene product; RTPCR, reverse transcriptionPCR
| Introduction |
|---|
|
|
|---|
Normal human cells have a limited proliferative potential in vitro. After a finite, cell-type specific number of cell divisions, cells cease to divide and arrest in a viable G0/G1 state termed replicative senescence (1,2). On the other hand, most human tumor-derived cells grow indefinitely and are designated immortal (3), suggesting that senescence is a mechanism of tumor suppression (4), and that immortalization of normal cells is a significant step in carcinogenesis.
Inactivation by SV40 large T antigen or human papillomavirus type 16 (HPV-16) E6 and E7 oncoproteins of cell cycle regulatory gene products, such as p53 and the retinoblastoma gene product (pRb), can extend the replicative lifespan of human fibroblasts, but rarely induce immortalization of the cells (5), suggesting that additional genetic event(s) are required for human cell immortalization. Inactivation of the other cell cycle regulatory gene product p16INK4a, which is an inhibitor of an enzyme complex containing a cyclin D and cyclin-dependent kinase (CDK) 4/6 that phosphorylates pRb (6), is also implicated in mediating human cell immortalization (7,8). p16INK4a is inactivated in many tumors through mutation, deletion or hypermethylation of the gene, leading to phosphorylation and inactivation of pRb (8). Loss of p16INK4a protein expression is not only common in tumor-derived cell lines (6,9), but observed in several in vitro immortalized human cell lines (9,10). Several lines of evidence using human normal cells (11) and tumor-derived cells (1214) indicate an inverse relationship of p16INK4a and pRb function in a common pathway. Kiyono et al. (15) found that introduction of either HPV-16 E6 or human telomerase catalytic subunit (hTERT) cDNA alone into human foreskin keratinocytes or mammary epithelial cells fails to immortalize the cells, but that inactivation of the p16INK4a/pRb pathway by HPV-16 E7 or down-regulation of p16INK4a expression in combination with activation of telomerase is able to immortalize the cells. Requirement of inactivation of p16INK4a and pRb functions accompanied by activation of telomere maintenance mechanisms, including telomerase or an alternative mechanism known as ALT (alternative lengthening of telomeres) (16), is also demonstrated in human fibroblast cell lines immortalized by introduction of HPV-16 E6, E7 or both E6 and E7, as described previously (17,18).
Loss of p16INK4a expression is also demonstrated in non-virally immortalized human cells, i.e. spontaneously immortalized human fibroblasts derived from patients with the LiFraumeni syndrome (18) and the human fibroblast cell line SUSM-1 immortalized by a chemical carcinogen 4-nitroquinoline 1-oxide (4-NQO) (9). These immortal cells maintain or lengthen their telomeres by either telomerase or the ALT mechanism (9,10), but the status of pRb phosphorylation in these cells is unclear. All these findings suggest the association of p16INK4a and pRb inactivation accompanied by activation of telomere maintenance mechanisms with immortalization of human cells including epithelial cells and fibroblasts and prompted our experiments to determine the expression status of p16INK4a and pRb in in vitro established human cell lines. In addition, we compared the expression status of p16INK4a and pRb between telomerase-positive and ALT-positive immortal cell lines. Furthermore, we studied the expression status of p21WAF1/CIP1 in the immortal cell lines, because p21WAF1/CIP1 inhibits cyclin-dependent kinase activity (for a review, see ref. 20), is highly expressed in senescent normal human fibroblasts (7), and induces senescence when expressed in immortal cells (10). Brown et al. (21) also report that inactivation of WAF1/CIP1 gene by two sequential rounds of targeted homologous recombination is sufficient to bypass senescence in normal human fibroblasts.
| Materials and methods |
|---|
|
|
|---|
Cell lines
The cell lines used are shown in Table I
|
Methylation-specific PCR (MSP)
CpG island promoter methylation of INK4a in the immortal cell lines was studied by MSP. DNA was extracted from the immortal cell lines as described previously (21). The extracted DNA (1 µg) underwent a bisulfite modification by using a CpGenomeTM DNA modification kit (Intergen, Purchase, NY), and subsequently amplified with a CpG WizTM p16 amplification kit (Intergen) according to the manufacturer's instructions.
Reverse transcriptionPCR (RTPCR)
Total RNA in cells was isolated by the RNAzolTM B extraction according to the manufacturer's instructions (Tel-Test, Friendswood, TX). Total RNA (5 µg) was subjected to RT using the RTG You Prime First-Strand BeadsTM (Amersham Pharmacia Biotec, Tokyo, Japan). PCR was performed in the reaction mixture (100 µl) containing 1 µl of the RT reaction product, 25 µM dNTP, 0.1 µl [
-32P]dCTP (Amersham Pharmacia Biotec), 0.025 U of Taq DNA polymerase (Takara, Tokyo, Japan) and 50 pM of sense and antisense primers for INK4a (exon 1
) (29) or Rb (exon 2227) (30). RTPCR for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) served as an internal control. Each cycle consisted of denaturation at 94°C for 1 min, annealing for 1 min at either 56°C for INK4a or 55°C for Rb, amplification at 72°C for 2 min followed by a final elongation at 72°C for 5 min. After 35 cycles, a 20 µl aliquot of each reaction was subjected to polyacrylamide (6%) gel electrophoresis, stained with ethidium bromide, and visualized under UV illumination.
Western blot analysis
Western blots were performed by using the method described by Ikeda et al. (31) with a minor modification. Cells were lysed in buffer [0.1% Nonidet P-40/250 mM KCl/50 mM HEPES, pH 7.9/10% (v/v) glycerol/4 mM NaF/4 mM sodium orthovanadate/0.2 mM EDTA/0.2 mM EGTA/1 mM dithiothreitol/1 mM phenylmethylsulfonyl fluoride/1 aprotinin, pepstatin, and leupeptin each at 1 µg/ml]. Then, 50 µg of total protein per lane were run on a 6% SDSPAGE gel for pRb and a 12% SDSPAGE gel for p16INK4a and p21WAF1/CIP1 analyses and then transferred to nitrocellulose (Millipore, Tokyo, Japan). p16WAF1/CIP1 was observed with the p16INK4a monoclonal antibody (PharMingen, San Diego, CA), a horseradish peroxidase conjugated goat anti-mouse antibody (Santa Cruz Biotechnology, Santa Cruz, CA), and detection by enhanced chemiluminescence (Amersham Pharmacia Biotech). The blot was exposed to X-ray films (RX-U, Fuji Film, Tokyo, Japan). pRb was observed with the pRb polyclonal antibody (C-15, Santa Cruz Biotechnology), while p21WAF1/CIP1 was observed with the p21WAF1/CIP1 polyclonal antibody (C-19, Santa Cruz Biotechnology). Both pRb and p21WAF1/CIP1 blotting used a horseradish peroxidase conjugated goat anti-donkey antibody (Santa Cruz Biotechnology), followed by detection with enhanced chemiluminescence (Amersham Pharmacia Biotech). The probe for extracellular-signal related kinase 1 (ERK1) was used as an internal control.
Telomerase assay
Telomerase activity in cells was detected by the telomeric repeat amplification protocol (TRAP) developed and modified by Shay's group (32). Cells (106) in the logarithmic growth phase were suspended in 100 µl of ice-cold lysis buffer [0.5% CHAPS, 10 mM TrisHCl (pH 7.5), 1 mM MgCl2, 1 mM EGTA, 5 mM ß-mercaptoethanol, 0.1 mM AEBSF (a protease inhibitor) and 10% glycerol], and kept on ice for 30 min with occasional tapping. The lysate was centrifuged at 16 000 g for 20 min at 4°C. The supernatant (1 µl: equivalent to 104 cells) was assayed in 50 µl of reaction mixture containing 50 µM of each deoxynucleoside triphosphate, 344 nM of the deoxyoligonucleotide primer TS(5'-AATCCGTCGAGCAGAGTT-3'), 0.5 µM T4 gene 32 protein (Boehringer Mannheim), 4 µCi [
-32P]deoxycytidine triphosphate (sp. act. ~3000 Ci/mmol, Amersham Pharmacia Biotech), 2 U of Taq DNA polymerase (Takara) and 5 µl of 10x PCR buffer in a 0.5 ml tube that contained 344 nM of the deoxyoligonucleotide primer CX(5'-CCTTACCCTTACCCTTACCCTAA-3') sequestered from the other reaction components by a wax barrier. After 20 min incubation at room temperature, the reaction mixture was amplified by PCR for 31 cycles in the presence of 5 attograms of an internal TRAP assay standard (ITAS: generously provided by E.Hiyama, Hiroshima University, Hiroshima, Japan). The PCR product was subjected to electrophoresis on 10% polyacrylamide gels.
| Results |
|---|
|
|
|---|
First, we confirmed our previous findings on the involvement of inactivation of p16INK4a and pRb in immortalization of the E6-expressing fibroblast cell line WHE-7 E6 Cl 6. We also examined the expression status of p16INK4a and pRb in the human gingival keratinocyte cell line Epi E6 immortalized by HPV-E6 alone, because the requirement of p16INK4a/pRb inactivation was suggested for immortalization of E6-expressing human mammary epithelial cells (15). As shown in Figure 1
|
|
|
We next examined the expression status of p16INK4a, pRb, and p21WAF1/CIP1 in physical or chemical carcinogen-induced immortal fibroblasts. Although detected in the parental KMS-6, DNA sequences in the INK4a promoter region in the 60Co-immortalized cell line KMST-6 were undetectable with PCR analysis (Figure 1
|
As shown in Figure 2
Although p16INK4a expression was observed in KMS-6, OUMS-24 and MDAH 087, their immortal cell lines expressed undetectable p16INK4a (Figure 3
). pRb proteins of these immortal cell lines were in a hyperphosphorylated state (Figure 3
). The expression of p21WAF1/CIP1 was up-regulated in OUMS-24F and LCS-ST, but down-regulated in KMST-6 and the other four LCS cell lines compared with their parental cells (Figure 3
).
It was previously demonstrated that WHE-7 E6 Cl 6 is telomerase-positive, and the other immortal fibroblast cell lines are ALT-positive (17,23). As shown in Figure 5
, TRAP assay showed that Epi E6 was positive for telomerase activity. When compared the expression status of p16INK4a and pRb between the telomerase-positive immortal cell lines and the ALT-positive immortal cell lines, as well as between immortal cell lines consisting of fibroblasts or keratinocytes, there were no significant differences (Figure 3
).
|
Inactivation of p16INK4a/pRb pathway is necessary but not sufficient for human cell immortalization (15). Activation of the telomere maintenance mechanisms is considered as an additional genetic event (15). Thus, we examined the requirement of telomerase activity for immortalization of human fibroblasts. In this experiment, we studied the expression status of p16INK4a and pRb in the following three human fibroblasts infected with a retrovirus vector encoding hTERT cDNA, i.e. WHEt, Ayt and Pelt, each of which was obtained by introduction of hTERT cDNA into WHE-7 cells at 9 PD, Ay cells at 8 PD or Pel cells at 9 PD, respectively. The cumulative growth of these three cells after infection is shown in Figure 6
|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
The status of p16INK4a, pRb, or p21WAF1/CIP1 expressions was examined using in vitro immortalized human cell lines including fibroblasts and keratinocytes, in which telomere lengths were maintained either by activation of telomerase or by activation of the ALT mechanism (17). The results are summarized in Table II
|
p16INK4a is commonly deleted in human cancers and cancer cell lines through mutation, deletion or methylation of the gene (for a review, see ref. 8). Most non-virally immortalized cell lines have no detectable expression of p16INK4a (6,9,11,14,34). The 5-methyl cytosine content of cellular DNA in normal fibroblasts from mice decreases markedly with an increase in the number of population doublings, and after the spontaneous immortalization, it increases to the level found in young fibroblasts (35). Either exposure of spontaneously immortalized human fibroblasts expressing no detectable p16INK4a protein to the demethylating agent 5-aza-2'-deoxycytidine or infection of the immortal fibroblasts with a retrovirus vector encoding INK4a cDNA induces the expression of p16INK4a protein and senescence in the immortal cells (10). These suggest the involvement of INK4a methylation in spontaneous immortalization of mammalian fibroblasts.
The CpG island within the promoter region of INK4a was methylated in the E6-immortalized fibroblast cell line, WHE-7 E6 Cl 6, which exhibited loss of mRNA and protein expressions for INK4a. Although INK4a CpG island was unmethylated, expressions of INK4a mRNA and protein were not observed in the E6-immortalized keratinocyte cell line, Epi E6. As the PCR method for detection of methylation examines only a limited subset of the CpG dinucleotides in this island, the loss of INK4a expression may be due to methylation that the primers do not detect. Alternatively, some mutation in the INK4a may reflect the loss of INK4a expression because Epi E6 shows loss of heterozygosity when assayed for the genomic region D9S161 or D9S171 adjacent to the INK4a. The cell line, KMST-6, immortalized by 60Co showed deletion of DNA sequences within the promoter region of INK4a, but contained a normal exon 1 INK4a. Loss of heterozygosity is observed at D9S171 locus near the genomic region of the INK4a in KMST-6. Deletion of the INK4a promoter may be a causal mechanism of the loss of p16INK4a expression in this cell line. Although expressed INK4a mRNA, the 4-NQO-immortalized cell line OUMS-24F failed to express its translated protein, which may be due to harborage of nonsense or frameshift mutations in the INK4a gene, or due to either defects of INK4a mRNA at the level of processing and translation or enhanced degradation of the p16INK4a protein, as shown in many types of human carcinoma cell lines (6). Loss of p16INK4a expression in the five LCS cell lines immortalized either spontaneously or by aflatoxin B1 or X-rays can be attributed to methylation of the promoter region of INK4a.
Introduction of hTERT cDNA into normal human fibroblasts results in a considerable extension of replicative lifespan (for a review, see ref. 8), However, MacKenzie et al. (36) report that introduction of hTERT is not sufficient for immortalization of normal human fibroblasts. Telomerase activity induced by hTERT cDNA alone is not sufficient for immortalization of normal human keratinocytes as well, and telomerase activity accompanied by inactivation of the p16INK4a/pRb pathway induces immortalization of the cells (15). In the present study using human fibroblasts infected with a retrovirus vector encoding hTERT cDNA, we demonstrated that activation of telomerase activity alone was not sufficient for immortalization of human fibroblasts. Inactivation of both p16INK4a and pRb pathways was required for immortalization of human fibroblasts with telomerase activity. This is a novel finding which differs from the results of others (37,38) who report the absence of cancer- or transformation-associated changes in human fibroblasts by introduction of hTERT cDNA. We have previously shown that loss of p16INK4a and pRb functions accompanied by activation of the ALT mechanism is also required for immortalization of human fibroblasts (17). These findings suggest that inactivation of p16INK4a and pRb pathway together with activation of the telomere maintenance mechanism is required for immortalization of human fibroblasts.
The expression of p21WAF1/CIP1 was reduced or absent in the cell lines immortalized by HPV-E6, but it varied among the cell lines immortalized either spontaneously or by physical or chemical carcinogens, indicating the lack of common alterations in the p21WAF1/CIP1 expression. Spontaneously immortalized human fibroblasts following treatment with 5-aza-2'-deoxycytidine which elevates the level of p16INK4a undergo senescence with no detectable change in the expression of p21WAF1/CIP1 (10). These results suggest the level of p21WAF1/CIP1 expression itself is of little significance for immortalization of human cells.
In summary, we demonstrated in the present study that all the immortal cell lines including fibroblasts and keratinocytes exhibited inactivation of p16INK4a and pRb functions. Loss of p16INK4a and pRb functions alone, or activation of telomere maintenance mechanism alone was not sufficient for immortalizing normal human cells. These findings indicate the requirement of inactivation of p16INK4a and pRb pathways, accompanied by activation of telomere maintenance mechanism, for immortalization of normal human cells.
| Notes |
|---|
4 To whom correspondence should be addressed Email: barrett{at}mail.nih.gov
| References |
|---|
|
|
|---|
- Hayflick,L. (1965) The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res., 37, 614636.[Web of Science][Medline]
- Rheinwald,J.G. and Green,H. (1975) Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell, 6, 331343.[Web of Science][Medline]
- Stamps,A.C., Gusterson,B.A. and O'Hare,M.J. (1992) Are tumours immortal? Eur. J. Cancer, 28A, 14951500.[Web of Science][Medline]
- Sager,R. (1989) Tumor suppressor genes: the puzzle and the promise. Science, 246, 14061412.
[Abstract/Free Full Text] - Shay,J.W., Pereira-Smith,O.M. and Wright,W.E. (1991) A role for both RB and p53 in the regulation of human cellular senescence. Exp. Cell Res., 196, 3339.[Web of Science][Medline]
- Okamoto,A., Demetrick,D.J., Spillare,E.A., et al. (1994) Mutations and altered expression of p16INK4a in human cancer. Proc. Natl Acad. Sci. USA, 91, 1104511049.
[Abstract/Free Full Text] - Alcorta,D.A., Xiong,Y., Phelps,D., Hannon,G., Beach,D. and Barrett,J.C. (1996) Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl Acad. Sci. USA, 93, 1374213747.
[Abstract/Free Full Text] - Huschtscha,L.I. and Reddel,R.R. (1999) p16INK4a and the control of cellular proliferative life span. Carcinogenesis, 20, 921926.
[Abstract/Free Full Text] - Whitaker,N.J., Bryan,T.M., Bonnefin,P., Chang,A.C.-M., Musgrove,E.A., Braithwaite,A.W. and Reddel,R.R. (1995) Involvement of RB-1, p53, p16INK4a and telomerase in immortalization of human cells. Oncogene, 11, 971976.[Web of Science][Medline]
- Vogt,M., Haggblom,C., Yeargin,J., Christiansen-Weber,T. and Haas,M. (1998) Independent induction of senescence by p16INK4a and p21CIP1 in spontaneously immortalized human fibroblasts. Cell Growth Differ., 9, 139146.[Abstract]
- Yeager,T., Stadler,W., Belair,C., Puthenveettil,J., Olopade,O. and Reznikoff,C. (1995) Increased p16 levels correlate with pRb alterations in human urothelial cells. Cancer Res., 55, 493497.
[Abstract/Free Full Text] - Jarrard,D.F., Sarkar,S., Shi,Y., et al. (1999) p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells. Cancer Res., 59, 29572964.
[Abstract/Free Full Text] - Ueki,K., Ono,Y., Henson,J.W., Efird,J.T., von Deimling,A. and Louis,D.N. (1996) CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res., 56, 150153.
[Abstract/Free Full Text] - Otterson,G.A., Kratzke,R.A., Coxon,A., Kim,Y.W. and Kaye,F.J. (1994) Absence of p16INK4a protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene, 9, 33753378.[Web of Science][Medline]
- Kiyono,T., Foster,S.A., Koop,J.I., McDougall,J.K., Galloway,D.A. and Klingelhutz,A.J. (1998) Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature, 396, 8488.[Medline]
- Bryan,T.M., Englezou,A., Dalla-Pozza,L., Dunham,M.A. and Reddel,R.R. (1997) Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nature Med., 3, 12711274.[Web of Science][Medline]
- Kumakura,S., Yamamoto,A., Yagisawa,J., Uchida,M. and Tsutsui,T. (2002) Telomere length and telomerase activity in the process of human fibroblast immortalization. Odontology, 90, 1321.[Medline]
- Rogan,E.M., Bryan,T.M., Hukku,B., et al. (1995) Alterations in p53 and p16INK4a expression and telomere length during spontaneous immortalization of LiFraumeni syndrome fibroblasts. Mol. Cell. Biol., 15, 47454753.[Abstract]
- Morgan,D.O. (1995) Principles of CDK regulation. Nature, 374, 131134.[Medline]
- Brown,J.P., Wei,W. and Sedivy,J.M. (1997) Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science, 277, 831834.
[Abstract/Free Full Text] - Tsutsui,T., Tanaka,Y., Matsudo,Y., Hasegawa,K., Fujino,T., Kodama,S. and Barrett,J.C. (1997) Extended lifespan and immortalization of human fibroblasts induced by X-ray irradiation. Mol. Carcinog., 18, 718.[Web of Science][Medline]
- Namba,M., Nishitani,K., Hyodoh,F., Fukushima,F. and Kimoto,T. (1985) Neoplastic transformation of human diploid fibroblasts (KMST-6) by treatment with 60Co gamma rays. Int. J. Cancer, 35, 275280.[Web of Science][Medline]
- Sugihara,S., Mihara,K., Marunouchi,T., Inoue,H. and Namba,M. (1996) Telomere elongation observed in immortalized human fibroblasts by treatment with 60Co gamma rays or 4-nitroquinoline 1-oxide. Hum. Genet., 97, 16.[Web of Science][Medline]
- Bai,L., Mihara,K., Kondo,Y., Honma,M. and Namba,M. (1993) Immortalization of normal human fibroblasts by treatment with 4-nitroquinoline 1-oxide. Int. J. Cancer, 53, 451456.[Web of Science][Medline]
- Bischoff,F.Z., Yim,S.O., Pathak,S., Grant,G., Siciliano,M.J., Giovanella,B.C., Strong,L.C. and Tainsky,M.A. (1990) Spontaneous abnormalities in normal fibroblasts from patients with LiFraumeni cancer syndrome: aneuploidy and immortalization. Cancer Res., 50, 79797984.
[Abstract/Free Full Text] - Tsutsui,T., Fujino,T., Kodama,S., Tainsky,M.A., Boyd,J. and Barrett,J.C. (1995) Aflatoxin B1-induced immortalization of cultured skin fibroblasts from a patient with LiFraumeni syndrome. Carcinogenesis, 16, 2534.
[Abstract/Free Full Text] - Rokukawa,A. and Tsutsui,T. (1997) Study of the ability of tetracyclines to induce chromosome aberrations in cultured human fibroblasts derived from gingival tissues [in Japanese]. J. Japan. Soc. Periodont., 39, 338347.
- Omori,N., Kobayashi,H. and Tsutsui,T. (1999) Quantitative comparison of cytocidal effects of tetracyclines and fluoroquinolones on human periodontal ligament fibroblasts. J. Periodont. Res., 34, 290295.[Web of Science][Medline]
- Song,S.H., Jong,H.-S., Choi,H.H., Kang,S.H., Ryu,M.H., Kim,N.K., Kim,W.-H. and Bang,Y.-J. (2000) Methylation of specific CpG sites in the promoter region could significantly down-regulate p16INK4a expression in gastric adenocarcinoma. Int. J. Cancer, 87, 236240.[Web of Science][Medline]
- Liu,Y., Szekely,L., Grandér,D., Söderhäll,S., Juliusson,G., Gahrton,G., Linder,S. and Einhorn,S. Chronic lymphocytic leukemia cells with allelic deletions at 13q14 commonly have one intact RB1 gene: evidence for a role of an adjacent locus. (1993) Proc. Natl Acad. Sci. USA, 90, 86978701.
[Abstract/Free Full Text] - Ikeda,M., Jakoi,L. and Nevins,J.R. (1996) A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl Acad. Sci. USA, 93, 32153220.
[Abstract/Free Full Text] - Wright,W.E., Shay,J.E. and Piatyszek,M.A. (1995) Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res., 23, 37943795.
[Free Full Text] - Jacobs,J.J.L., Kieboom,K., Marino,S., DePinho,R.A. and van Lohuizen,M. (1999) The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature, 397, 164168.[Medline]
- Khleif,S.N., DeGregori,J., Yee,C.L., Otterson,G.A., Kaye,F.J., Nevins,J.R. and Howley,P.M. (1996) Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc. Natl Acad. Sci. USA, 93, 43504354.
- Wilson,V.L. and Jones,P.A. (1983) DNA methylation decreases in aging but not in immortal cells. Science, 220, 10551057.
[Abstract/Free Full Text] - MacKenzie,K.L., Franco,S., May,C., Sadelain,M. and Moore,M.A.S. (2000) Mass cultured human fibroblasts overexpressing hTERT encounter a growth crisis following an extended period of proliferation. Exp. Cell. Res., 259, 336350.[Web of Science][Medline]
- Jiang,X-R., Jimenez,G., Chang,E., et al. (1999) Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nature Genet., 21, 111114.[Web of Science][Medline]
- Morales,C.P., Holt,S.E., Ouellette,M., Kaur,K. J., Yan,Y., Wilson,K.S., White,M.A., Wright,W.E. and Shay,J.W. (1999) Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nature Genet., 21, 115118.[Web of Science][Medline]
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Shai, H. C. Pitot, and P. F. Lambert p53 Loss Synergizes with Estrogen and Papillomaviral Oncogenes to Induce Cervical and Breast Cancers Cancer Res., April 15, 2008; 68(8): 2622 - 2631. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, J. Zhang, Y. Fang, C. Zhao, and Y. Zhu Ginsenoside Rg1 Delays Tert-Butyl Hydroperoxide-Induced Premature Senescence in Human WI-38 Diploid Fibroblast Cells J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2008; 63(3): 253 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shai, T. Brake, C. Somoza, and P. F. Lambert The Human Papillomavirus E6 Oncogene Dysregulates the Cell Cycle and Contributes to Cervical Carcinogenesis through Two Independent Activities Cancer Res., February 15, 2007; 67(4): 1626 - 1635. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. W. Wen, K. Wu, S. Baksh, R. A. Hinshelwood, R. B. Lock, S. J. Clark, M. A.S. Moore, and K. L. MacKenzie Telomere-Driven Karyotypic Complexity Concurs with p16INK4a Inactivation in TP53-Competent Immortal Endothelial Cells. Cancer Res., November 15, 2006; 66(22): 10691 - 10700. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Fridman, L. Tang, O. I. Kulaeva, B. Ye, Q. Li, F. Nahhas, P. C. Roberts, S. J. Land, J. Abrams, and M. A. Tainsky Expression profiling identifies three pathways altered in cellular immortalization: interferon, cell cycle, and cytoskeleton. J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2006; 61(9): 879 - 889. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Kim, J. Rowe, H. Fujii, R. Jones, B. Schmierer, B.-W. Kong, K. Kuchler, D. Foster, D. Ish-Horowicz, and G. Peters Upregulation of chicken p15INK4b at senescence and in the developing brain J. Cell Sci., June 15, 2006; 119(12): 2435 - 2443. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zongaro, E. de Stanchina, T. Colombo, M. D'Incalci, E. Giulotto, and C. Mondello Stepwise Neoplastic Transformation of a Telomerase Immortalized Fibroblast Cell Line Cancer Res., December 15, 2005; 65(24): 11411 - 11418. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Milyavsky, Y. Tabach, I. Shats, N. Erez, Y. Cohen, X. Tang, M. Kalis, I. Kogan, Y. Buganim, N. Goldfinger, et al. Transcriptional Programs following Genetic Alterations in p53, INK4A, and H-Ras Genes along Defined Stages of Malignant Transformation Cancer Res., June 1, 2005; 65(11): 4530 - 4543. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Taylor, A. James, C. E. Schuller, J. Brce, R. B. Lock, and K. L. MacKenzie Inactivation of p16INK4a, with Retention of pRB and p53/p21cip1 Function, in Human MRC5 Fibroblasts That Overcome a Telomere-independent Crisis during Immortalization J. Biol. Chem., October 15, 2004; 279(42): 43634 - 43645. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. McMurray and D. J. McCance Degradation of p53, Not Telomerase Activation, by E6 Is Required for Bypass of Crisis and Immortalization by Human Papillomavirus Type 16 E6/E7 J. Virol., June 1, 2004; 78(11): 5698 - 5706. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Milyavsky, I. Shats, N. Erez, X. Tang, S. Senderovich, A. Meerson, Y. Tabach, N. Goldfinger, D. Ginsberg, C. C. Harris, et al. Prolonged Culture of Telomerase-Immortalized Human Fibroblasts Leads to a Premalignant Phenotype Cancer Res., November 1, 2003; 63(21): 7147 - 7157. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||















